No Data
No Data
Express News | The Osaka government in Japan instructed Kobayashi Pharmaceutical to dispose of approximately 416,000 products.
Kobayashi Pharmaceutical: Extraordinary Report
Kobayashi Pharmaceutical To Go Ex-Dividend On December 27th, 2024 With 59 JPY Dividend Per Share
December 26th (Japan Standard Time) - $Kobayashi Pharmaceutical(4967.JP)$ is trading ex-dividend on December 27th, 2024.Shareholders of record on December 31st, 2024 will receive 59 JPY dividend per
Express News | Oasis Management Raises Stake in Kobayashi Pharmaceutical to 10.1% From 7.54%, Filing Shows
Goldman Sachs: The yen has dropped to a value point, creating the best opportunity for foreign capital to Buy Japanese stocks.
Goldman Sachs believes that the yen is the best choice for global Japanese stock buyers.
Intertrade Research Memo (5): The fiscal year ending September 2024 will see a decrease in revenue and a significant drop in profit. The main financial solutions will be a burden.
■ The performance trend of Intertrade <3747> 1. Performance for the fiscal year ending September 2024 The consolidated performance for the fiscal year ending September 2024 shows revenue of 1,849 million yen (a decrease of 8.1% from the previous year), operating profit of 80 million yen (a decrease of 59.8% from the previous year), ordinary loss of 159 million yen (compared to a profit of 1 million yen in the previous year), and a net loss attributable to the parent company's Shareholders of 97 million yen (compared to a profit of 36 million yen in the previous year), resulting in a landing below the initial plan in all items. In terms of revenue, the Business Solutions segment has increased revenue by 16.1%.
No Data